UBS Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $137M | Buy |
2,077,277
+945,821
| +84% | +$60.1M | 0.02% | 822 |
|
|
2025
Q4 | $71.9M | Sell |
1,131,456
-671,795
| -37% | -$41.8M | 0.01% | 1283 |
|
|
2025
Q3 | $99.1M | Sell |
1,803,251
-1,267,414
| -41% | -$52.2M | 0.02% | 1036 |
|
|
2025
Q2 | $101M | Buy |
3,070,665
+936,446
| +44% | +$32.6M | 0.02% | 945 |
|
|
2025
Q1 | $85.8M | Buy |
2,134,219
+932,220
| +78% | +$42.8M | 0.02% | 1027 |
|
|
2024
Q4 | $56.5M | Buy |
1,201,999
+888,440
| +283% | +$46.1M | 0.01% | 1351 |
|
|
2024
Q3 | $16.6M | Buy |
313,559
+13,955
| +5% | +$778K | ﹤0.01% | 1978 |
|
|
2024
Q2 | $16.2M | Buy |
299,604
+860
| +0.3% | +$51.9K | 0.01% | 1847 |
|
|
2024
Q1 | $20.9M | Buy |
298,744
+24,436
| +9% | +$1.89M | 0.01% | 1647 |
|
|
2023
Q4 | $22.9M | Buy |
274,308
+77,637
| +39% | +$2.81M | 0.01% | 1504 |
|
|
2023
Q3 | $5.79M | Sell |
196,671
-104,833
| -35% | -$3.49M | ﹤0.01% | 2433 |
|
|
2023
Q2 | $9.84M | Buy |
301,504
+51,174
| +20% | +$1.89M | ﹤0.01% | 1973 |
|
|
2023
Q1 | $8.81M | Sell |
250,330
-84,887
| -25% | -$3.46M | ﹤0.01% | 1982 |
|
|
2022
Q4 | $15.4M | Buy |
335,217
+124,320
| +59% | +$5.35M | 0.01% | 1606 |
|
|
2022
Q3 | $10.2M | Buy |
210,897
+46,415
| +28% | +$2.23M | 0.01% | 1775 |
|
|
2022
Q2 | $6.46M | Sell |
164,482
-83,540
| -34% | -$3.36M | ﹤0.01% | 2166 |
|
|
2022
Q1 | $9.13M | Buy |
248,022
+3,649
| +1% | +$130K | ﹤0.01% | 2010 |
|
|
2021
Q4 | $11.1M | Buy |
244,373
+109,869
| +82% | +$4.24M | ﹤0.01% | 2048 |
|
|
2021
Q3 | $4.81M | Buy |
134,504
+107,854
| +405% | +$3.18M | ﹤0.01% | 2714 |
|
|
2021
Q2 | $528K | Sell |
26,650
-61,604
| -70% | -$1.45M | ﹤0.01% | 4685 |
|
|
2021
Q1 | $2.05M | Buy |
88,254
+85,091
| +2,690% | +$1.82M | ﹤0.01% | 3544 |
|
|
2020
Q4 | $66K | Buy |
3,163
+652
| +26% | +$11.9K | ﹤0.01% | 5952 |
|
|
2020
Q3 | $55K | Buy |
2,511
+159
| +7% | +$3.72K | ﹤0.01% | 5577 |
|
|
2020
Q2 | $55K | Sell |
2,352
-17,937
| -88% | -$336K | ﹤0.01% | 5773 |
|
|
2020
Q1 | $239K | Sell |
20,289
-31,797
| -61% | -$406K | ﹤0.01% | 4585 |
|
|
2019
Q4 | $552K | Sell |
52,086
-45,275
| -47% | -$465K | ﹤0.01% | 4752 |
|
|
2019
Q3 | $1.11M | Buy |
97,361
+75,833
| +352% | +$952K | ﹤0.01% | 3877 |
|
|
2019
Q2 | $242K | Buy |
21,528
+16,569
| +334% | +$160K | ﹤0.01% | 4791 |
|
|
2019
Q1 | $40K | Sell |
4,959
-76,839
| -94% | -$565K | ﹤0.01% | 5717 |
|
|
2018
Q4 | $517K | Buy |
81,798
+74,860
| +1,079% | +$549K | ﹤0.01% | 4239 |
|
|
2018
Q3 | $68K | Buy |
6,938
+5,377
| +344% | +$43.1K | ﹤0.01% | 5916 |
|
|
2018
Q2 | $13K | Sell |
1,561
-53,349
| -97% | -$444K | ﹤0.01% | 6978 |
|
|
2018
Q1 | $396K | Buy |
54,910
+38,105
| +227% | +$327K | ﹤0.01% | 4353 |
|
|
2017
Q4 | $137K | Sell |
16,805
-8,047
| -32% | -$91.4K | ﹤0.01% | 5174 |
|
|
2017
Q3 | $361K | Buy |
24,852
+20,891
| +527% | +$285K | ﹤0.01% | 4459 |
|
|
2017
Q2 | $48K | Sell |
3,961
-10,320
| -72% | -$143K | ﹤0.01% | 5671 |
|
|
2017
Q1 | $183K | Buy |
14,281
+2,060
| +17% | +$24.1K | ﹤0.01% | 4697 |
|
|
2016
Q4 | $148K | Buy |
12,221
+7,920
| +184% | +$84K | ﹤0.01% | 5000 |
|
|
2016
Q3 | $40K | Buy |
4,301
+1,786
| +71% | +$18.6K | ﹤0.01% | 5692 |
|
|
2016
Q2 | $24K | Hold |
2,515
| – | – | ﹤0.01% | 6145 |
|
|
2016
Q1 | $18K | Sell |
2,515
-25,975
| -91% | -$190K | ﹤0.01% | 6280 |
|
|
2015
Q4 | $298K | Buy |
28,490
+25,946
| +1,020% | +$254K | ﹤0.01% | 4354 |
|
|
2015
Q3 | $17K | Sell |
2,544
-579
| -19% | -$3.95K | ﹤0.01% | 6846 |
|
|
2015
Q2 | $21K | Buy |
3,123
+579
| +23% | +$3.8K | ﹤0.01% | 6821 |
|
|
2015
Q1 | $17K | Sell |
2,544
-3,420
| -57% | -$25.5K | ﹤0.01% | 7138 |
|
|
2014
Q4 | $48K | Buy |
+5,964
| New | +$25.6K | ﹤0.01% | 6523 |
|
Other funds holding CYTK
VPM
VCM
ACA
